Long-term results of conversion of roux-en-y gastric bypass to biliopancreatic diversion with duodenal switch
Roux-en-Y gastric bypass represents historically an important step forward in bariatric surgery, offering an effective treatment for obesity and its many related comorbidities.1 This operation provides a safe, broadly accepted, and technically reproducible technique with clinically outcomes that, to a large extent, mark the bar by which we compare most other bariatric and metabolic treatments.2 The limitations of the procedure are well documented. The RYGB design presents many technical and physiologic challenges. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - March 21, 2024 Category: Surgery Authors: Peter C. Ng Tags: Editorial Source Type: research
Utilization of Anti-obesity Medications After Bariatric Surgery: Analysis of a Large National Database
ConclusionDespite a relatively high incidence of weight regain, AOMs are underutilized following bariatric surgery. It is imperative that barriers to their use be addressed and that AOMs be considered earlier and more frequently in patients with insufficient weight loss or weight regain after bariatric surgery.Graphical Abstract (Source: Obesity Surgery)
Source: Obesity Surgery - March 21, 2024 Category: Surgery Source Type: research
Single anastomosis duodenal switch versus Roux-en-Y gastric bypass in patients with BMI ≥ 50 kg/m2: a multi-centered comparative analysis
ConclusionsIn our cohort, SADI-S was associated with higher and sustained weight-loss results compared to RYGB. Comorbidity resolution was also higher after SADI-S. Both procedures demonstrate a similar safety profile. Further studies are required to validate the long-term safety of SADI-S compared to other bariatric procedures. (Source: Surgical Endoscopy)
Source: Surgical Endoscopy - March 20, 2024 Category: Surgery Source Type: research
Early Marginal Ulcer After Roux-en-Y Gastric Bypass: MBSAQIP Database Analysis of Trends and Predictive Factors
ConclusionsThe incidence of 30-day MU following RYGB was 0.3%. Patients with MU required endoscopic interventions, readmissions, and reoperations at rates of 88%, 72%, and 9%, respectively. Some preoperative and intraoperative factors contributed to an increased risk of 30-day MU.Graphical Abstract (Source: Obesity Surgery)
Source: Obesity Surgery - March 19, 2024 Category: Surgery Source Type: research
Effect of anti-reflux suture on gastroesophageal reflux symptoms after one anastomosis gastric bypass: a randomized controlled trial
ConclusionGERD symptoms and de novo GERD after OAGB seems to be under-reported after OAGB. This study suggests that applying an anti-reflux suture can decrease de novo GERD symptoms.Graphical abstract (Source: Surgical Endoscopy)
Source: Surgical Endoscopy - March 18, 2024 Category: Surgery Source Type: research
A Leak Post One Anastomosis Gastric Bypass Following Misoprostol Treatment
Isr Med Assoc J. 2024 Mar;26(3):191-192.NO ABSTRACTPMID:38493332 (Source: The Israel Medical Association Journal)
Source: The Israel Medical Association Journal - March 17, 2024 Category: General Medicine Authors: Amram Kupietzky Roi Dover Ata Maden Nachum Emil Eliezer Lourie Ronit Grinbaum Source Type: research
